Metabolomics Insights in Mood Disorders

Metabolomics, the systematic study of small-molecule metabolites in biological systems, has emerged as a powerful tool to unravel the biochemical underpinnings of mood disorders. By profiling the global metabolome in blood, cerebrospinal fluid and other matrices, researchers can trace perturbations in energy pathways, neurotransmitter precursors, lipid mediators and gut microbiota–derived compounds that reflect both genetic predisposition and environmental exposures. In major depressive disorder, alterations have been observed in amino acid turnover—particularly glutamate and tryptophan metabolism—implicating excitatory neurotransmission and the kynurenine pathway in pathogenesis. Lipidomic analyses have highlighted changes in lysophosphatidic acids and other phospholipids, suggesting membrane remodelling and signalling dysregulation. Moreover, shifts in central energy metabolites—such as pyruvate and adenosine triphosphate—point to mitochondrial dysfunction and altered bioenergetics across mood states. Integration of metabolomic data with clinical variables and psychosocial factors has fostered multivariate models that can stratify patients by risk, predict treatment response and identify potential resilience factors. Such approaches have underscored the role of diet and the gut–brain axis, revealing microbiota-derived metabolites as actionable targets for nutritional interventions. As high-throughput platforms advance and machine-learning algorithms become more sophisticated, metabolomics promises to refine diagnostic criteria, unveil novel therapeutic targets and support personalised strategies in mood disorder management. Ongoing efforts aim to standardise protocols, validate biomarkers in diverse populations and translate findings into routine clinical assays.

Research from Nature Portfolio

No recent Nature Portfolio content available.

Metabolomics Insights in Mood Disorders publication trend

The graph below shows the total number of articles in metabolomics insights in mood disorders across all publications each year (not limited to Nature Index journals).

Technical terms

Metabolomics: Comprehensive analysis of metabolites within a biological sample to characterise biochemical processes.

Ultra-high-performance liquid chromatography–tandem mass spectrometry (UHPLC-MS/MS): A sensitive analytical technique that separates and identifies metabolites by mass and charge.

Random forest: A machine-learning algorithm that constructs multiple decision trees to improve prediction accuracy and handle complex data relationships.

Hippurate: A gut microbial co-metabolite of dietary polyphenols implicated in host–microbiome interactions and mood regulation.

Pyruvate: A central energy metabolite linking glycolysis and the tricarboxylic acid cycle, indicative of mitochondrial function.

References

1. Circulating metabolites modulated by diet are associated with depression. Molecular Psychiatry (2023).
2. A multivariate blood metabolite algorithm stably predicts risk and resilience to major depressive disorder in the general population. EBioMedicine (2023).
3. The Utility of Amino Acid Metabolites in the Diagnosis of Major Depressive Disorder and Correlations with Depression Severity. International Journal of Molecular Sciences (2023).